These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17090665)

  • 1. Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia.
    Fantacci M; Bianciardi P; Caretti A; Coleman TR; Cerami A; Brines M; Samaja M
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17531-6. PubMed ID: 17090665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury.
    Fiordaliso F; Chimenti S; Staszewsky L; Bai A; Carlo E; Cuccovillo I; Doni M; Mengozzi M; Tonelli R; Ghezzi P; Coleman T; Brines M; Cerami A; Latini R
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2046-51. PubMed ID: 15671158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia.
    Liu W; Shen Y; Plane JM; Pleasure DE; Deng W
    Exp Neurol; 2011 Aug; 230(2):227-39. PubMed ID: 21596035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling pathways of cell proliferation are involved in the differential effect of erythropoietin and its carbamylated derivative.
    Chamorro ME; Wenker SD; Vota DM; Vittori DC; Nesse AB
    Biochim Biophys Acta; 2013 Aug; 1833(8):1960-8. PubMed ID: 23602701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamylated erythropoietin ameliorates hypoxia-induced cognitive and behavioral defects with the generation of choline acetyltransferase-positive neurons.
    Ding J; Li QY; Yu JZ; Wang X; Lu CZ; Ma CG; Xiao BG
    J Neurosci Res; 2013 Jan; 91(1):73-82. PubMed ID: 23074165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamylated Erythropoietin Outperforms Erythropoietin in the Treatment of AKI-on-CKD and Other AKI Models.
    Tögel FE; Ahlstrom JD; Yang Y; Hu Z; Zhang P; Westenfelder C
    J Am Soc Nephrol; 2016 Nov; 27(11):3394-3404. PubMed ID: 26984884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat.
    King VR; Averill SA; Hewazy D; Priestley JV; Torup L; Michael-Titus AT
    Eur J Neurosci; 2007 Jul; 26(1):90-100. PubMed ID: 17614942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection and CD131/GDNF/AKT Pathway of Carbamylated Erythropoietin in Hypoxic Neurons.
    Ding J; Wang J; Li QY; Yu JZ; Ma CG; Wang X; Lu CZ; Xiao BG
    Mol Neurobiol; 2017 Sep; 54(7):5051-5060. PubMed ID: 27541284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
    Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamylated erythropoietin ameliorates cyclosporine nephropathy without stimulating erythropoiesis.
    Abe T; Isaka Y; Imamura R; Kakuta Y; Okumi M; Yazawa K; Ichimaru N; Tsuda H; Nonomura N; Takahara S; Okuyama A
    Cell Transplant; 2012; 21(2-3):571-80. PubMed ID: 22410315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lack of CD131 and the inhibition of Neuro-2a growth by carbamylated erythropoietin.
    Ding J; Li QY; Yu JZ; Wang X; Lu CZ; Ma CG; Xiao BG
    Cell Biol Toxicol; 2015 Feb; 31(1):29-38. PubMed ID: 25656842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory Improvement in the AβPP/PS1 Mouse Model of Familial Alzheimer’s Disease Induced by Carbamylated-Erythropoietin is Accompanied by Modulation of Synaptic Genes.
    Armand-Ugón M; Aso E; Moreno J; Riera-Codina M; Sánchez A; Vegas E; Ferrer I
    J Alzheimers Dis; 2015; 45(2):407-21. PubMed ID: 25790933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats.
    Liu X; Zhu B; Zou H; Hu D; Gu Q; Liu K; Xu X
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1263-72. PubMed ID: 25725621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties.
    Moon C; Krawczyk M; Paik D; Coleman T; Brines M; Juhaszova M; Sollott SJ; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2006 Mar; 316(3):999-1005. PubMed ID: 16306273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
    Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
    Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nonerythropoietic derivative of erythropoietin inhibits tubulointerstitial fibrosis in remnant kidney.
    Imamura R; Isaka Y; Sandoval RM; Ichimaru N; Abe T; Okumi M; Yazawa K; Kitamura H; Kaimori J; Nonomura N; Rakugi H; Molitoris BA; Takahara S
    Clin Exp Nephrol; 2012 Dec; 16(6):852-62. PubMed ID: 22678524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of HIF-1alpha or HIF-2alpha to erythropoietin expression: in vivo evidence based on chromatin immunoprecipitation.
    Yeo EJ; Cho YS; Kim MS; Park JW
    Ann Hematol; 2008 Jan; 87(1):11-7. PubMed ID: 17712557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).
    Kirkeby A; Torup L; Bochsen L; Kjalke M; Abel K; Theilgaard-Monch K; Johansson PI; Bjørn SE; Gerwien J; Leist M
    Thromb Haemost; 2008 Apr; 99(4):720-8. PubMed ID: 18392330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of PHD and HSP90 on erythropoietin production in yak (Bos grunniens) renal interstitial fibroblast-like cells under hypoxia.
    Cui Y; Li H; Yu SJ; Afedo SY; Bai XF
    J Mol Histol; 2022 Apr; 53(2):395-411. PubMed ID: 35084636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia.
    Souvenir R; Flores JJ; Ostrowski RP; Manaenko A; Duris K; Tang J
    Transl Stroke Res; 2014 Feb; 5(1):118-27. PubMed ID: 24323731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.